Compound: EHT-1864

Drug Target: RAC1, RAC2, RAC3

Drug Target pathway: Cytoskeleton

Dataset



Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.